Alogliptin benzoate

This classification denotes an anti-diabetic agent C18H21N5O2.C7H6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EEN99869SC, chemically known as benzonitrile, 2-((6-((3r)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl)methyl)-, monobenzoate, but more generally known as alogliptin benzoate, which bears US NIH Compound Identifier 16088021. European Medicines Agency schedules Alogliptin benzoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32165. Most nations, for tariff and trade purposes, schedule alogliptin benzoate under HS 29335990 and SITC 51576. As of Q4 2014, ALOGLIPTIN BENZOATE remains US FDA's Preferred Term for this commodity. Alogliptin benzoate bears US NLM identifiers UMLS ID C1958127 and NCI Concept Code C75186. SMILES: CN1C(=O)CC(N(C1=O)CC2CCCCC2C#N)N3CCC[C@H](C3)N.C1CCC(CC1)C(=O)O.